Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone is more effective than cryotherapy for treating alopecia areata in middle-aged adults.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Fractional infrared technology is effective and safe for treating cervical laxity.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Skin problems are common in thyroid disorders, with dry skin in hypothyroidism and warm, soft skin in hyperthyroidism.

Social media can help compare the effectiveness and safety of new arthritis medications.

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Gene therapy in mice increased lifespan and improved health without causing cancer.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Early diagnosis and treatment of TPP can prevent complications.

Skin reactions from cancer treatments might predict how well the treatments work.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Some synthesized peptides improved cell growth better than thymosin β4, VEGF, and minoxidil.

Platelet-rich plasma treatment is effective for hair loss in patients regardless of their thyroid antibody levels.

KeraGLO improves skin and hair health.

Thymosin β4 and VEGF are important for organ function and may help with blood vessel formation.

A new compound shows promise as a topical treatment for hair loss.

Laser treatment and deroofing are effective options for hidradenitis suppurativa.

AMT® shows promise as a safe and effective treatment for early-stage knee osteoarthritis.

DHEA therapy improves pubic hair growth and psychological well-being in young females with central adrenal insufficiency.

Recognizing macro-TSH is crucial to avoid unnecessary treatments.

RXRα is crucial for hair growth and skin cell function.

Thyroid disorders are linked to skin issues and autoimmune skin diseases.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

A woman with a drug allergy to anakinra was successfully desensitized, allowing her to continue treatment without allergic reactions.